Piboserod Completed Phase 2 Trials for Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00041496Prevention Of Recurrence Of Atrial Fibrillation